FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1182165780> ?p ?o ?g. }

• W1182165780 endingPage "195" @default.
• W1182165780 startingPage "191" @default.
• W1182165780 abstract "Aims and background Thymic tumors (thymomas and thymic carcinomas) represent 50% of all mediastinal tumors. Thymomas usually express high levels of somatostatin receptors, which enable in vivo imaging with 111In-DTPA-octreotide (OctreoScan®). The aim of this study was to further investigate the role of radionuclide techniques in the diagnosis, staging and follow-up of these tumors. Methods Eight patients (5 women, 3 men, age range 35-79 years; mean ± SD 56.1 ± 15.8 years) entered the study. In 4 patients, myasthenia gravis was the presenting symptom. 111In-DTPA-octreotide scan was performed within 3 weeks after contrast enhanced CT and/or MRI. Planar and tomographic images were acquired within 24 hours of the injection of 111 MBq OctreoScan. The scintigraphic results were defined in correlation with the histological findings. Results Histology revealed thymoma in 3 patients, thymic carcinoma in 1, insular carcinoma of presumably thymic origin in 1, thymic carcinoid in 1, and thymic hyperplasia in 2 patients. Two thymomas were at stage I, 1 thymoma and 1 thymic carcinoma at stage II, 1 insular carcinoma of presumably thymic origin at stage IV, and 1 thymic carcinoid at stage IV. OctreoScan consistently accumulated in primary and/or metastatic sites of thymic tumors while no radiotracer uptake was detected in the 2 patients with benign thymic hyperplasia. In 1 patient with a very large mediastinal mass (13 cm in largest diameter) and multiple metastatic deposits in the lungs, OctreoScan scintigraphy showed a large area of pathological uptake in the anterior mediastinum and a small area of focal uptake in the cervical-dorsal region of the right lung corresponding to a lymph node expressing somatostatin receptors. Conclusions OctreoScan is avidly taken up by thymic tumors, enabling the diagnosis of these tumors and a better evaluation of their extension. It does not accumulate in thymic hyperplasia, thus allowing the differential diagnosis between these 2 pathological conditions. In patients affected by myasthenia gravis, OctreoScan scintigraphy can play an important role in characterizing thymic masses." @default.
• W1182165780 created "2016-06-24" @default.
• W1182165780 creator A5009975966 @default.
• W1182165780 creator A5014483372 @default.
• W1182165780 creator A5020627929 @default.
• W1182165780 creator A5028413341 @default.
• W1182165780 creator A5035599522 @default.
• W1182165780 creator A5039994913 @default.
• W1182165780 creator A5054090215 @default.
• W1182165780 creator A5059462029 @default.
• W1182165780 creator A5077600317 @default.
• W1182165780 creator A5091526871 @default.
• W1182165780 creator A5091719044 @default.
• W1182165780 date "2011-03-01" @default.
• W1182165780 modified "2023-09-23" @default.
• W1182165780 title "Current role of 111In-DTPA-octreotide scintigraphy in diagnosis of thymic masses." @default.
• W1182165780 cites W1596824624 @default.
• W1182165780 cites W1806679283 @default.
• W1182165780 cites W1819549830 @default.
• W1182165780 cites W1963940642 @default.
• W1182165780 cites W1981326638 @default.
• W1182165780 cites W1991069433 @default.
• W1182165780 cites W2013839190 @default.
• W1182165780 cites W2021735427 @default.
• W1182165780 cites W2033927603 @default.
• W1182165780 cites W2064652200 @default.
• W1182165780 cites W2069386429 @default.
• W1182165780 cites W2112838511 @default.
• W1182165780 cites W2442741688 @default.
• W1182165780 cites W3188803436 @default.
• W1182165780 doi "https://doi.org/10.1700/667.7782" @default.
• W1182165780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21617714" @default.
• W1182165780 hasPublicationYear "2011" @default.
• W1182165780 type Work @default.
• W1182165780 sameAs 1182165780 @default.
• W1182165780 citedByCount "7" @default.
• W1182165780 countsByYear W11821657802014 @default.
• W1182165780 countsByYear W11821657802016 @default.
• W1182165780 countsByYear W11821657802017 @default.
• W1182165780 countsByYear W11821657802018 @default.
• W1182165780 countsByYear W11821657802019 @default.
• W1182165780 crossrefType "journal-article" @default.
• W1182165780 hasAuthorship W1182165780A5009975966 @default.
• W1182165780 hasAuthorship W1182165780A5014483372 @default.
• W1182165780 hasAuthorship W1182165780A5020627929 @default.
• W1182165780 hasAuthorship W1182165780A5028413341 @default.
• W1182165780 hasAuthorship W1182165780A5035599522 @default.
• W1182165780 hasAuthorship W1182165780A5039994913 @default.
• W1182165780 hasAuthorship W1182165780A5054090215 @default.
• W1182165780 hasAuthorship W1182165780A5059462029 @default.
• W1182165780 hasAuthorship W1182165780A5077600317 @default.
• W1182165780 hasAuthorship W1182165780A5091526871 @default.
• W1182165780 hasAuthorship W1182165780A5091719044 @default.
• W1182165780 hasConcept C126322002 @default.
• W1182165780 hasConcept C126838900 @default.
• W1182165780 hasConcept C142724271 @default.
• W1182165780 hasConcept C146357865 @default.
• W1182165780 hasConcept C151730666 @default.
• W1182165780 hasConcept C2776297358 @default.
• W1182165780 hasConcept C2776349617 @default.
• W1182165780 hasConcept C2777546739 @default.
• W1182165780 hasConcept C2778105408 @default.
• W1182165780 hasConcept C2779126056 @default.
• W1182165780 hasConcept C2779159893 @default.
• W1182165780 hasConcept C2779902710 @default.
• W1182165780 hasConcept C2781025020 @default.
• W1182165780 hasConcept C2910722220 @default.
• W1182165780 hasConcept C71924100 @default.
• W1182165780 hasConcept C86803240 @default.
• W1182165780 hasConceptScore W1182165780C126322002 @default.
• W1182165780 hasConceptScore W1182165780C126838900 @default.
• W1182165780 hasConceptScore W1182165780C142724271 @default.
• W1182165780 hasConceptScore W1182165780C146357865 @default.
• W1182165780 hasConceptScore W1182165780C151730666 @default.
• W1182165780 hasConceptScore W1182165780C2776297358 @default.
• W1182165780 hasConceptScore W1182165780C2776349617 @default.
• W1182165780 hasConceptScore W1182165780C2777546739 @default.
• W1182165780 hasConceptScore W1182165780C2778105408 @default.
• W1182165780 hasConceptScore W1182165780C2779126056 @default.
• W1182165780 hasConceptScore W1182165780C2779159893 @default.
• W1182165780 hasConceptScore W1182165780C2779902710 @default.
• W1182165780 hasConceptScore W1182165780C2781025020 @default.
• W1182165780 hasConceptScore W1182165780C2910722220 @default.
• W1182165780 hasConceptScore W1182165780C71924100 @default.
• W1182165780 hasConceptScore W1182165780C86803240 @default.
• W1182165780 hasIssue "2" @default.
• W1182165780 hasLocation W11821657801 @default.
• W1182165780 hasOpenAccess W1182165780 @default.
• W1182165780 hasPrimaryLocation W11821657801 @default.
• W1182165780 hasRelatedWork W1992809940 @default.
• W1182165780 hasRelatedWork W2000658226 @default.
• W1182165780 hasRelatedWork W2006910370 @default.
• W1182165780 hasRelatedWork W2018559275 @default.
• W1182165780 hasRelatedWork W2019852726 @default.
• W1182165780 hasRelatedWork W2032227677 @default.
• W1182165780 hasRelatedWork W2044483124 @default.
• W1182165780 hasRelatedWork W2064652200 @default.
• W1182165780 hasRelatedWork W2072852471 @default.

• next